WC
TDACU icon

Wealthspring Capital’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Wealthspring Capital’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,360
Closed -$602K – 158
2025
Q1 		$602K Hold
59,360
– – 0.93% 30
2024
Q4 		$595K Buy
+59,360
New +$595K 0.9% 31

Other funds holding TDACU

Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Flow Traders U.S.
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealthspring Capital's TDACU Position: Q2 2025 in Review

Wealthspring Capital sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 59,360 shares — an estimated $602K sold.

Wealthspring Capital first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $602K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Wealthspring Capital reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Wealthspring Capital sold 59,360 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $602K.
  • Wealthspring Capital first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Wealthspring Capital's Translational Development Acquisition Corp Units position peaked at $602K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Wealthspring Capital's 13F filing for Q2 2025, filed 6 Aug 2025.